NIH-funded research R01 grant

Immunomodulatory nanofiber gel to help chronic wounds heal faster

Official title: Immunomodulatory Nanofibrous Modular Aerogels for Chronic Wound Healing

Funded at Terasaki Institute for Biomedical Innovation · NIH-11347242 · Data updated 2026-11-12

A research team is testing a tiny, advanced gel made of nanofibers and peptides to steer immune cells toward healing so chronic wounds can close sooner.

More Wound research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionTerasaki Institute for Biomedical Innovation
NIH-funded
Lab location1 site (Woodland Hills, UNITED STATES)
Project startSeptember 5, 2026
Project endMay 31, 2030
Funding year2026
Award (this year)$393,800
NIH project number1R01GM164582-01
Project IDNIH-11347242 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates are adults with chronic wounds (e.g., diabetic, venous, or pressure ulcers) that have not healed with standard care.

Less likely to help

Patients with acute wounds or wounds that are already healing well may not benefit from this approach.

What this research studies

Chronic wounds affect millions and cost billions, largely because immune cells stay in a damaging inflammatory state. The project aims to deliver short, stable peptide fragments that shift macrophages from a pro-inflammatory M1 state to a pro-healing M2 state, speeding tissue repair. To tackle oxygen issues in wounds, they’re also testing an innovative oxygen-generating system to reduce hypoxia and support healing. The approach combines immunomodulatory materials with controlled oxygen release to create a more favorable wound environment. If successful, this could lead to faster healing and less complications for people with diabetic, venous, or pressure ulcers.

Why it matters

Potential benefit: If successful, patients with chronic wounds could heal faster and reduce infection risk and healthcare costs.

How similar studies have gone: Prior work indicates macrophage polarization can influence healing, and peptide fragments may offer improved stability and activity over whole PRG-4 protein.

Where this research is happening

  • Terasaki Institute for Biomedical Innovation
    Woodland Hills, United States
    Active

Researchers

  • Principal investigator: Vitharikunnil John, Johnson — Terasaki Institute for Biomedical Innovation
  • Study coordinator: Vitharikunnil John, Johnson

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.